Position
Chief Executive Officer
Company
a United States-based clinical-stage oncology specialist
Palo AltoBiotechnology ResearchDescription
On November 2, 2026, Guardant Health's Board approved performance-based restricted stock units for its Co-CEOs, Helmy Eltoukhy and AmirAli Talasaz. Each received 465,413 PSUs aimed at aligning their compensation with the company's long-term performance. The PSUs are contingent on achieving specific total shareholder return targets
Who to call at a United States-based clinical-stage oncology specialist, and when
A new leader at a United States-based clinical-stage oncology specialist brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day a United States-based clinical-stage oncology specialist raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at a United States-based clinical-stage oncology specialist, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at a United States-based clinical-stage oncology specialist. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment a United States-based clinical-stage oncology specialist changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
a United States-based clinical-stage oncology specialist changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.